Cyabra, Inc. (CYAB) is a Tel Aviv-based, Nasdaq-listed software company whose AI platform helps governments, defense agencies and enterprises detect coordinated inauthentic behavior, bot networks, deepfakes and narrative manipulation online. In the opening half hour of Tuesday's session, the stock traded at $0.0939, down 31.37% from Monday's close of $0.1368 and 6.7 cents below the session's first print. There was no new press release, filing or analyst action behind the decline. Instead, the move extends a violent reversal that began inside Monday's own session, when a $45 million investment framework lifted the shares more than 100% intraday before the rally failed and the stock closed far below its high.
No verified news or fundamental catalyst found for Tuesday's session. The decline is best read as the second leg of Monday's failed breakout: a single headline drove a parabolic intraday advance to $0.2662, the stock then gave back more than half of that gain before the close, and sellers pressed the advantage at Tuesday's opening bell. That sequence — a gap up on news, a rejection at the highs, and a gap down the following morning — is consistent with speculative momentum unwinding rather than a new deterioration in the business. Turnover remains the tell: roughly 2.3 million shares traded in the first 27 minutes, a busy pace but a fraction of Monday's several-hundred-million-share churn, which was dozens of times the normal daily volume. In a micro-cap with a thin order book, that kind of volume vacuum leaves little support once the initial demand fades.
The financing that powered Monday's surge is also the reason it has not held. The Nov. 15 securities purchase agreement provides for an initial subscription of $15.61 million — $10 million in new cash plus $5.61 million satisfied by cancelling $2.8 million of debt — with up to $30 million more available in $500,000 tranches over three years. The newly designated Series D preferred converts at $0.15 per share, and the accompanying warrants carry the same initial exercise price. On paper, the initial tranche alone would convert into more than 100 million shares, several times the roughly 35 million currently outstanding. The company also cut the exercise price on two existing warrant series covering more than 16 million shares from $0.50 and $0.45 to $0.15, adding a one-time anti-dilution adjustment tied to the pending reverse split. For a company last valued near $3 million, that is an enormous potential share supply.
Investors are also weighing what the agreement does not yet include. The initial closing has not occurred, no proceeds have been received, and completion depends on stockholder approval and on the company curing Nasdaq continued-listing deficiencies — the same minimum-bid problem that led shareholders on Nov. 10 to authorize a reverse split of between one-for-two and one-for-thirty, with the ratio left to the board. A $50 million equity line remains under negotiation, and a registration statement for resale of the underlying shares must be filed within two business days of closing. Layered on top are a widening net loss, about $0.8 million of cash at the last report, and a $1.5 million secured note arranged with Alpha Capital Anstalt in early November. The gap between "up to $45 million" and cash in hand is unusually wide.
The decline was not a sector event. Broad technology and small-cap benchmarks were essentially flat to slightly lower, and there was no macro release or AI-software headline driving sympathy selling. Cyabra's move was more than four times its own recent volatility: over the past 60 sessions the stock has averaged an absolute daily change of about 6.7%, and only twice in that stretch has it moved further than it has today — Monday's 54% advance and a 45% jump in late August, both gains. Tuesday's gap below the $0.10 area broke the psychological round-number level and left the shares near the low end of the year's range, with Monday's $0.1215 intraday low now acting as overhead resistance rather than support.
On a scale where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news paired with an extreme, rare price move, Cyabra scores 54 out of 100. The verified news is substantive: a financing framework of up to $45 million for a company worth roughly $3 million is material by any measure, even if its conversion terms are aggressively dilutive and nothing has closed. The price move was about 4.7 times the stock's typical daily swing over the past 60 sessions, and a comparable move appeared only twice in that window. Strong but double-edged news plus an unusual, not unprecedented, decline produces the mid-range score.
The near-term calendar is dominated by execution rather than operations. Investors will look for the initial closing around December, the special meeting to approve share issuance, and the board's decision on the reverse-split ratio needed to regain bid-price compliance. Filing of the resale registration statement will make the new share supply visible and tradeable. On the fundamental side, Cyabra's last reported quarter showed revenue of about $1.9 million, up roughly 39% year over year with gross margins near 84%, and consensus models call for full-year 2026 revenue of about $8.1 million rising toward $14.4 million in 2027; both covering analysts rate the shares a Buy. The risks are equally clear: a cash position measured in months, dilution that could dwarf the existing share count, listing risk, and a shareholder base that has already seen the stock lose the overwhelming majority of its value over the past year.
Tickeron's Trending AI Robots page curates the automated strategies delivering the strongest results under present market conditions, drawn from a library of hundreds of bots covering thousands of tickers. Each bot differs by approach, holding period, performance statistics and the symbols it trades, so the featured roster rotates as market leadership shifts. For traders navigating volatile names like this one, it is a practical starting point for comparing live strategy performance rather than relying on a single view. Review the current leaders and see which setups match your time horizon.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for CYAB moved out of oversold territory on November 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 9 of the 13 cases the stock moved higher. This puts the odds of a move higher at 69%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 15 of 44 cases where CYAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 34%.
The Momentum Indicator moved above the 0 level on November 16, 2026. You may want to consider a long position or call options on CYAB as a result. In 19 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 28%.
The Moving Average Convergence Divergence (MACD) for CYAB just turned positive on October 20, 2026. Looking at past instances where CYAB's MACD turned positive, the stock continued to rise in 11 of 42 cases over the following month. The odds of a continued upward trend are 26%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where CYAB advanced for three days, in 32 of 86 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
CYAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
The Aroon Indicator for CYAB entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.130) is normal, around the industry mean (16.188). P/E Ratio (-0.061) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (0.671) is also within normal values, averaging (103.301).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. CYAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications